Acylphosphatase 1, Erythrocyte (ACYP1) Antibody
286€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Acylphosphatase 1, Erythrocyte (ACYP1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx130603
tested applications
WB, IHC, IF/ICC
Description
Acylphosphatase 1, Erythrocyte Antibody is a Rabbit Polyclonal against Acylphosphatase 1, Erythrocyte.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Acylphosphatase 1, Erythrocyte (ACYP1) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | erythrocyte isozyme,Acylphosphate phosphohydrolase 1 |
| Background | Antibody anti-ACYP1 |
| Status | RUO |
Descripción
Acylphosphatase 1 (ACYP1) is a small cytosolic enzyme that catalyzes the hydrolysis of acyl-phosphate bonds in a variety of substrates, including 1,3-bisphosphoglycerate and carbamoyl phosphate. ACYP1 is primarily expressed in erythrocytes and the brain, where it is thought to play a role in maintaining energy homeostasis and regulating cellular metabolism. It may also influence signaling pathways by modulating the levels of phosphorylated intermediates. ACYP1 has been implicated in oxidative stress responses and apoptosis, as its dysregulation is associated with increased susceptibility to oxidative damage. Mutations or altered expression of ACYP1 may contribute to neurological disorders and metabolic diseases, though its precise physiological roles remain under investigation.
